Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147720199> ?p ?o ?g. }
- W2147720199 endingPage "1493" @default.
- W2147720199 startingPage "1487" @default.
- W2147720199 abstract "Acute kidney injury (AKI) represents a worldwide public health issue of increasing incidence, with a significant morbi-mortality. AKI treatment mostly relies on supportive manoeuvres in the absence of specific target-oriented therapy. The pathophysiology of AKI commonly involves ischaemia/reperfusion (I/R) events, which cause both immune and metabolic consequences in renal tissue. Similarly, at the time of kidney transplantation (KT), I/R is an unavoidable event which contributes to early graft dysfunction and enhanced graft immunogenicity. Mesenchymal stromal cells (MSCs) represent a heterogeneous population of adult, fibroblast-like multi-potent cells characterized by their ability to differentiate into tissues of mesodermal lineages. Because MSC have demonstrated immunomodulatory, anti-inflammatory and tissue repair properties, MSC administration at the time of I/R and/or at later times has been hypothesized to attenuate AKI severity and to accelerate the regeneration process. Furthermore, MSC in KT could help prevent both I/R injury and acute rejection, thereby increasing graft function and survival. In this review, summarizing the encouraging observations in animal models and in pilot clinical trials, we outline the benefit of MSC therapy in AKI and KT, and envisage their putative role in renal ischaemic conditioning." @default.
- W2147720199 created "2016-06-24" @default.
- W2147720199 creator A5009133064 @default.
- W2147720199 creator A5026331753 @default.
- W2147720199 creator A5027884455 @default.
- W2147720199 creator A5038015672 @default.
- W2147720199 creator A5048127760 @default.
- W2147720199 creator A5050692336 @default.
- W2147720199 creator A5061357967 @default.
- W2147720199 creator A5084444254 @default.
- W2147720199 creator A5085178023 @default.
- W2147720199 date "2014-02-09" @default.
- W2147720199 modified "2023-10-07" @default.
- W2147720199 title "Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion" @default.
- W2147720199 cites W1600258010 @default.
- W2147720199 cites W1607358746 @default.
- W2147720199 cites W1906307758 @default.
- W2147720199 cites W1968159361 @default.
- W2147720199 cites W1976509351 @default.
- W2147720199 cites W1990950572 @default.
- W2147720199 cites W1991460349 @default.
- W2147720199 cites W1994229336 @default.
- W2147720199 cites W1998928623 @default.
- W2147720199 cites W2000133923 @default.
- W2147720199 cites W2001592750 @default.
- W2147720199 cites W2004650050 @default.
- W2147720199 cites W2010002771 @default.
- W2147720199 cites W2014808841 @default.
- W2147720199 cites W2016189233 @default.
- W2147720199 cites W2019609198 @default.
- W2147720199 cites W2021479300 @default.
- W2147720199 cites W2023301282 @default.
- W2147720199 cites W2030927418 @default.
- W2147720199 cites W2031407394 @default.
- W2147720199 cites W2036348189 @default.
- W2147720199 cites W2038217510 @default.
- W2147720199 cites W2041914058 @default.
- W2147720199 cites W2046237540 @default.
- W2147720199 cites W2049737910 @default.
- W2147720199 cites W2069399162 @default.
- W2147720199 cites W2074676962 @default.
- W2147720199 cites W2088581630 @default.
- W2147720199 cites W2092810335 @default.
- W2147720199 cites W2093366031 @default.
- W2147720199 cites W2093836304 @default.
- W2147720199 cites W2103591331 @default.
- W2147720199 cites W2116086770 @default.
- W2147720199 cites W2122241182 @default.
- W2147720199 cites W2123753106 @default.
- W2147720199 cites W2125107400 @default.
- W2147720199 cites W2136586552 @default.
- W2147720199 cites W2137961176 @default.
- W2147720199 cites W2141720233 @default.
- W2147720199 cites W2141832516 @default.
- W2147720199 cites W2144268541 @default.
- W2147720199 cites W2150951327 @default.
- W2147720199 cites W2152801307 @default.
- W2147720199 cites W2154215235 @default.
- W2147720199 cites W2167547107 @default.
- W2147720199 cites W2171497313 @default.
- W2147720199 cites W2371948111 @default.
- W2147720199 cites W4238559979 @default.
- W2147720199 cites W4239001479 @default.
- W2147720199 doi "https://doi.org/10.1093/ndt/gft538" @default.
- W2147720199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24516234" @default.
- W2147720199 hasPublicationYear "2014" @default.
- W2147720199 type Work @default.
- W2147720199 sameAs 2147720199 @default.
- W2147720199 citedByCount "56" @default.
- W2147720199 countsByYear W21477201992014 @default.
- W2147720199 countsByYear W21477201992015 @default.
- W2147720199 countsByYear W21477201992016 @default.
- W2147720199 countsByYear W21477201992017 @default.
- W2147720199 countsByYear W21477201992018 @default.
- W2147720199 countsByYear W21477201992019 @default.
- W2147720199 countsByYear W21477201992020 @default.
- W2147720199 countsByYear W21477201992021 @default.
- W2147720199 countsByYear W21477201992022 @default.
- W2147720199 crossrefType "journal-article" @default.
- W2147720199 hasAuthorship W2147720199A5009133064 @default.
- W2147720199 hasAuthorship W2147720199A5026331753 @default.
- W2147720199 hasAuthorship W2147720199A5027884455 @default.
- W2147720199 hasAuthorship W2147720199A5038015672 @default.
- W2147720199 hasAuthorship W2147720199A5048127760 @default.
- W2147720199 hasAuthorship W2147720199A5050692336 @default.
- W2147720199 hasAuthorship W2147720199A5061357967 @default.
- W2147720199 hasAuthorship W2147720199A5084444254 @default.
- W2147720199 hasAuthorship W2147720199A5085178023 @default.
- W2147720199 hasBestOaLocation W21477201992 @default.
- W2147720199 hasConcept C10882517 @default.
- W2147720199 hasConcept C126322002 @default.
- W2147720199 hasConcept C142724271 @default.
- W2147720199 hasConcept C1491633281 @default.
- W2147720199 hasConcept C16930146 @default.
- W2147720199 hasConcept C198826908 @default.
- W2147720199 hasConcept C203014093 @default.
- W2147720199 hasConcept C2780091579 @default.
- W2147720199 hasConcept C2780303639 @default.